In a paper published in the British Journal of Pharmacology today, scientists from the University of Reading and GW Research Ltd found that treating mice which have Dravet syndrome with purified botanical CBD showed improved mortality rates and lower scores for anxiety, depressive, cognitive and autistic-like social behavioural symptoms.
Those Dravet mice that received the CBD treatment scored significantly higher on a range of tests, and the team recorded that the treatment group scored similarly to healthy mice in all tests. The team did note that CBD did not show any significant effect on motor function, and they acknowledge that the paper was a non-clinical study carried out in mice.
Read more at: https://neurosciencenews.com/cbd-dravet-syndrome-death-16237/